Home
>
National Drug Code (NDC)
>
Betapace
Betapace - 50419-109-10 - (Sotalol Hydrochloride)
Drug Information of Betapace
| Product NDC: | 50419-109 |
| Proprietary Name: | Betapace |
| Non Proprietary Name: | Sotalol Hydrochloride |
| Active Ingredient(s): | 120 mg/1 & nbsp; Sotalol Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Betapace
| Product NDC: | 50419-109 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019865 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19921030 |
Package Information of Betapace
| Package NDC: | 50419-109-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (50419-109-10) |
NDC Information of Betapace
| NDC Code | 50419-109-10 |
| Proprietary Name | Betapace |
| Package Description | 100 TABLET in 1 BOTTLE (50419-109-10) |
| Product NDC | 50419-109 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sotalol Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19921030 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | SOTALOL HYDROCHLORIDE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |
